Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Capital Expenditures (2022 - 2023)

Historic Capital Expenditures for Therapeutics (LENZ) over the last 2 years, with Q2 2023 value amounting to $24000.0.

  • Therapeutics' Capital Expenditures fell 9826.71% to $24000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $30000.0, marking a year-over-year decrease of 9954.5%. This contributed to the annual value of $468000.0 for FY2024, which is 146000.0% up from last year.
  • Latest data reveals that Therapeutics reported Capital Expenditures of $24000.0 as of Q2 2023, which was down 9826.71% from $6000.0 recorded in Q1 2023.
  • In the past 5 years, Therapeutics' Capital Expenditures registered a high of $3.3 million during Q1 2022, and its lowest value of $6000.0 during Q1 2023.